Screener
PharmaCyte Biotech, Inc. PMCB Q4 2025 earnings
Reported December 18, 2025 · Before market open
EPS-$0.32
Next report
Dec 16, 2026 (in a month)EPS estimate-$0.06
Versus estimates
FAQ
- When did PharmaCyte Biotech, Inc. report Q4 2025 earnings?
- PharmaCyte Biotech, Inc. (PMCB) reported Q4 2025 earnings on December 18, 2025 before market open.
- What were PharmaCyte Biotech, Inc.'s Q4 2025 revenue and EPS?
- PharmaCyte Biotech, Inc. reported eps of $-0.32 for Q4 2025.
- How did PharmaCyte Biotech, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 10.3% from $-0.29.
- Where can I find PharmaCyte Biotech, Inc.'s Q4 2025 SEC filings?
- You can read the 10-Q periodic report (0001683168-25-009259) directly on SEC EDGAR. The filing index links above go to sec.gov.
